Prelude
Laguna Hills, California, United States · Biotechnology, Biotechnology Research, Health Care
PreludeDx is a precision diagnostics company dedicated to providing actionable tools for managing early-stage breast cancer. Its first test, DCISionRT, is the result of over a decade of research focused on DCIS and was developed using technology licensed from the University of California, San Francisco. Designed to address the critical question faced by DCIS patients — What is my risk of recurrenc
Key facts
- Headquarters
- Laguna Hills, California, United States
- Employees
- Unknown
- Industries
- Biotechnology, Biotechnology Research, Health Care
- Status
- Public (PRLD)
- Website
- preludedx.com
- Company page
Recent activity at Prelude
- : Prelude Corporation Appoints MiMi Reyes as Senior Vice President of Operations
- : Prelude
- : Paris-based Prelude raised €7.6 million in seed funding led by Singular and Seedcamp to expand its fraud-resistant SMS verification services across Europe and North America.
- : Prelude Corporation Appoints Dr. Pat Whitworth as Chief Medical Officer
- : PreludeDx Appoints Chris Emery, VP of Strategic Marketing and Business Development
- : Prelude Raises $24M To Help Organizations Harden Their Cybersecurity Defenses
- : Prelude Corp
- : Prelude Corp
- : Prelude Corp
- : Prelude Corp
Prelude funding history
| Date | Round | Amount |
|---|---|---|
| Nov 2025 | Venture | $5.0M |
| Nov 2024 | Seed | $7.6M |
| Apr 2022 | Funding Round | $24.0M |
| Feb 2022 | Venture | $9.3M |
| Jan 2020 | Venture | $10.0M |
Leadership
- Dan Forche, President and CEO
- Antonio Paternostro, Director of Sales & Business Development
- Marianthi Hatzis, Regional Sales Director
- Chris Emery, Vice President Strategic Marketing and Business Development
- MiMi Reyes, Senior Vice President of Operations
- Andrew Wade, Chief Financial Officer
- Paul-Louis Valat, Marketing Manager
- Christopher Woods, Vice President
- Pat Whitworth, Chief Medical Officer
Verified email and direct lines for Prelude’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Employee benefit plans
Prelude files 1 employee benefit plan with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
Prelude in the news
Companies similar to Prelude
- Sentinel Labs, Inc. · Biotechnology, Information Technology, Privacy And Security, Software
- Ping Identity · Information Technology, Privacy And Security, Software, Sustainability
- EchoIQ Limited · Biotechnology, Health Care, Information Technology, Software
- Pictor Labs · Biotechnology, Health Care, Information Technology, Software
- AvoMD · Biotechnology, Health Care, Information Technology, Software
About Prelude: questions and answers
What does Prelude do?
PreludeDx is a precision diagnostics company dedicated to providing actionable tools for managing early-stage breast cancer. Its first test, DCISionRT, is the result of over a decade of research focused on DCIS and was developed using technology licensed from the University of California, San Francisco. Designed to address the critical question faced by DCIS patients — What is my risk of recurrenc
Where is Prelude headquartered?
Prelude is headquartered in Laguna Hills, California, United States.
Has Prelude raised funding?
Yes. Fundz has recorded 5 funding events for Prelude. The most recent, $5.0M, was in Nov 2025.
Who leads Prelude?
Dan Forche is a President and CEO at Prelude.
What is the latest news on Prelude?
On Jan 22, 2026, Prelude Corporation Appoints MiMi Reyes as Senior Vice President of Operations
Is Prelude a public company?
Yes. Prelude is publicly traded under the ticker PRLD.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy